European Companies Search Engine

UK funding (£406,294): Regulation of capsule biosynthesis in the fungal pathogen Cryptococcus neoformans Ukri 1 Jun 2007 UK Research and Innovation, United Kingdom

Overview

Text

Regulation of capsule biosynthesis in the fungal pathogen Cryptococcus neoformans

Abstract We are trying to understand how fungal pathogens of humans adapt to conditions inside the body. This knowledge may identify additional ways to diagnose and treat these important infections. The concentration of carbon dioxide is 150 fold higher inside our body than in the air surrounding us. When fungal pathogens of humans sense the higher CO2 inside the host, they initiate a series of development changes, which permits it to infect that host. Previously we identified the CO2 sensor responsible for these changes. Now we want to investigate precisely how this enzyme senses CO2. CO2 serves other functions important for the survival of fungal pathogens. For example it is a fundamental part of basic cellular metabolism. We also propose to study whether the CO2 sensing enzyme is related to fungal metabolism.
Category Research Grant
Reference G0601049/1
Status Closed
Funded period start 01/06/2007
Funded period end 30/06/2010
Funded value £406,294.00
Source https://gtr.ukri.org/projects?ref=G0601049%2F1

Participating Organisations

UNIVERSITY OF KENT

The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: University of Kent, Canterbury.